Contact us (+ 7 (921) 446-25-10)
Texting is available for authorized users.
Please register or log in at the website.
Your request for online training is sent. Cbonds managers will be in touch with you shortly. Thank you!

Concorde Capital Research: Raiffeisen Bank Aval reports weak 2Q12 results

July 25, 2012 | Cbonds

Raiffeisen Bank Aval (BAVL UK) reported tiny net income of USD 0.7 mln as it kept allocating nearly all of its pre-impairment profit (which declined 28% yoy in 2Q12 and 15% yoy in 1H12) to loan loss reserve. Aval’s net interest income was down 7% yoy in 2Q12 as its net loan book contracted 6% qoq and 12% yoy. The decline in net interest revenues was only partly offset with stronger net fees and commissions (+9% yoy).

Olena Zuikova, analyst: The key concerns about Aval’s 2Q12 financials is continued rapid declines in assets and net loan book. Growth in operating expenses against weaker revenues is also a disappointment – the bank’s Cost/Income was up from 55% in 2Q11 to 67% in 2Q12. We expect the bank will report a nearly zero bottom line under UAS, but its net income under IFRS should be much stronger, with ROE expected to be near 10% with the discrepancy mainly attributed to different provisioning policies. We maintain a HOLD recommendation on the stock as the bank is facing risks of further contraction in its balance sheet and a related decline in revenue.

Company: Concorde Capital

Full company nameConcorde Capital
Country of riskUkraine
IndustryFinancial institutions


Similar news:
150 000
issues: local and international bonds
+7 812 336 97 21
150 000
issues: local and international bonds
Сbonds is a global Fixed income data platform
+7 812 336 97 21
  • Descriptive data on bonds
  • Bond Quotes from trading systems and market participants
  • Prospectuses and other issue documents
  • Credit ratings
  • Indices and indicators
  • Market news and analytical research
Analytical instruments
  • Multi-parameter bond database search
  • Bond Maps
  • Market calendar
  • Bond calculator
  • Watchlist and Portfolio management
  • Chart analysis
  • Mobile App and Excel Add-in Tool
Enter or RegisterSubscription/Trial access